Victoria Times Colonist It's now known that the Marchese bags containing cyclophosphamide and gemcitabine had too much saline, in effect watering down the prescribed drug concentrations by up to 20 per cent. Just over 1,200 cancer patients in Ontario and New Brunswick ... and more »
EurekAlert (press release) EORTC trial 40084-22084 has two primary objectives: to determine if adding erlotinib to gemcitabine adjuvant chemotherapy will improve survival as compared to gemcitabine alone following resection of head of pancreas adenocarcinoma, then, following ... and more »
Wall Street Journal Halozyme Therapeutics Inc. (HALO) said results were positive for an early-stage trial of its investigational new biologic, PEGPH20, in combination wi...
MarketWatch Halozyme announced in April the initiation of a Phase 2 study, a multicenter, randomized clinical trial evaluating PEGPH20 in combination with nab-paclitaxel and gemcitabine for the treatment of stage IV pancreatic cancer. Halozyme is also developing a ...
RTT News Of the 22 patients in the study with metastatic breast cancer, 11 patients that showed tumor progression after treatment with indoximod plus vaccine were subseq...
FierceBiotech Pharmexa reported that it terminated a Phase III study of GV1001 compared with Gemcitabine chemo in pancreatic cancer after preliminary data showed no su...
4-traders (press release) Patients were randomized to receive a standard chemotherapy regimen of carboplatin AUC 5 on Day 1 and gemcitabine 1000 mg/m2 on Day 1 and 8 of each 21-day cycle, with or without iniparib 5.6 mg/kg on Day 1, 4, 8 and 11. Patients in the study received ... and more »
PharmiWeb.com (press release) Consistent with LUX-Lung 3, afatinib* treatment led to significant and sustained tumour shrinkage compared to chemotherapy ( gemcitabine / cisplatin) in LUX-Lung 6. Specifically, in approximately two thirds of patients (66.9%) taking afatinib*, the ... and more »
StreetInsider.com (subscription) In the second study, results from a randomized Phase II trial of bavituximab plus gemcitabine in patients with non-resectable Stage IV...
